Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Carta

Showing results (11-20 of 83) with videos related to

Pageof 9
Sort By:
Frontiers in Molecular Neuroscience|May 15, 2018
Microglial Phagocytosis and Its Regulation: A Therapeutic Target in Parkinson's Disease?Elzbieta Janda, Laura Boi, Anna R Carta
Parkinson'S Disease|May 24, 2011
Do PPAR-Gamma Agonists Have a Future in Parkinson's Disease Therapy?Anna R Carta, Augusta Pisanu, Ezio Carboni
Neurotoxicity Research|April 24, 2007
The 6-hydroxydopamine model of Parkinson's diseaseNicola Simola, Micaela Morelli, Anna R Carta
Annales De Genetique Et De Selection Animale|August 14, 2012
[Not Available]R Carta, S Casu, J Flamant, et al.
Annales De Genetique Et De Selection Animale|August 17, 2012
[Not Available]J Flamant, S Casu, S Crochez, et al.
Neuroreport|August 16, 2000
Cocaine effects on gene regulation in the striatum and behavior: increased sensitivity in D3 dopamine receptor-deficient miceA R Carta, C R Gerfen, H Steiner
Frontiers in Neuroscience|May 17, 2021
Repurposing Ketamine in Depression and Related Disorders: Can This Enigmatic Drug Achieve Success?Ezio Carboni, Anna R Carta, Elena Carboni, et al.
Synapse (New York, N.Y.)|April 16, 2002
Differential regulation of GAD67, enkephalin and dynorphin mRNAs by chronic-intermittent L-dopa and A2A receptor blockade plus L-dopa in dopamine-denervated ratsAnna R Carta, Annalisa Pinna, Omar Cauli, et al.
Progress in Brain Research|April 6, 2020
The role of glia in Parkinson's disease: Emerging concepts and therapeutic applicationsKatarzyna Z Kuter, M Angela Cenci, Anna R Carta
The European Journal of Neuroscience|April 9, 2005
Different responsiveness of striatonigral and striatopallidal neurons to L-DOPA after a subchronic intermittent L-DOPA treatmentA R Carta, E Tronci, A Pinna, et al.
Pageof 9

Showing results (11-20 of 83) with videos related to

Sort By:
Pageof 9
Frontiers in Molecular Neuroscience|May 15, 2018
Microglial Phagocytosis and Its Regulation: A Therapeutic Target in Parkinson's Disease?Elzbieta Janda, Laura Boi, Anna R Carta
Parkinson'S Disease|May 24, 2011
Do PPAR-Gamma Agonists Have a Future in Parkinson's Disease Therapy?Anna R Carta, Augusta Pisanu, Ezio Carboni
Neurotoxicity Research|April 24, 2007
The 6-hydroxydopamine model of Parkinson's diseaseNicola Simola, Micaela Morelli, Anna R Carta
Annales De Genetique Et De Selection Animale|August 14, 2012
[Not Available]R Carta, S Casu, J Flamant, et al.
Annales De Genetique Et De Selection Animale|August 17, 2012
[Not Available]J Flamant, S Casu, S Crochez, et al.
Neuroreport|August 16, 2000
Cocaine effects on gene regulation in the striatum and behavior: increased sensitivity in D3 dopamine receptor-deficient miceA R Carta, C R Gerfen, H Steiner
Frontiers in Neuroscience|May 17, 2021
Repurposing Ketamine in Depression and Related Disorders: Can This Enigmatic Drug Achieve Success?Ezio Carboni, Anna R Carta, Elena Carboni, et al.
Synapse (New York, N.Y.)|April 16, 2002
Differential regulation of GAD67, enkephalin and dynorphin mRNAs by chronic-intermittent L-dopa and A2A receptor blockade plus L-dopa in dopamine-denervated ratsAnna R Carta, Annalisa Pinna, Omar Cauli, et al.
Progress in Brain Research|April 6, 2020
The role of glia in Parkinson's disease: Emerging concepts and therapeutic applicationsKatarzyna Z Kuter, M Angela Cenci, Anna R Carta
The European Journal of Neuroscience|April 9, 2005
Different responsiveness of striatonigral and striatopallidal neurons to L-DOPA after a subchronic intermittent L-DOPA treatmentA R Carta, E Tronci, A Pinna, et al.
Pageof 9